Literature DB >> 4138775

Propranolol in the surgical management of thyrotoxicosis.

P D Bewsher, C A Pegg, D J Stewart, D A Lister, W Michie.   

Abstract

Forty-nine thyrotoxic patients prepared for partial thyroidectomy with the beta-adrenoceptor blocking drug, propranolol, and iodine are compared with 42 patients prepared with carbimazole and iodine. The age and sex distribution of the two groups were comparable, but patients with obstructive airways disease and possible cardiac insufficiency were excluded from preparation with propranolol. The mean duration of preoperative treatment with propranolol was 40 days, compared with 89 days for carbimazole. Propranolol treated patients had lower pulse rates before and after operation. The serum PB(127)I values immediately before and after operation were higher in the propranolol group than in the carbimazole group, but were the same in both groups one and four months after operation. The incidence of hypothyroidism at one year after operation was 30% in the carbimazole prepared patients and 31% in the propranolol patients. Serum calcium levels were higher in the propranolol group at the time of operation. No adverse effects from the use of propranolol and at operation the thyroid gland prepared with propranolol was firmer, less friable, more easily mobilised and less likely to bleed than the gland prepared with carbimazole. There is, consequently, less risk of damage to the parathyroid glands and recurrent laryngeal nerves. However, the basal metabolic rate remains high on propranolol therapy and very careful supervision is advised.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138775      PMCID: PMC1343694          DOI: 10.1097/00000658-197411000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  GUANETHIDINE IN HYPERTHYROIDISM.

Authors:  S S WALDSTEIN; G H WEST; W Y LEE; D BRONSKY
Journal:  JAMA       Date:  1964-08-24       Impact factor: 56.272

2.  The acute hemodynamic effects of alpha-methyldopa in thyrotoxic patients and normal subjects.

Authors:  E O THEILEN; W R WILSON; F J TUTUNJI
Journal:  Metabolism       Date:  1963-07       Impact factor: 8.694

3.  The use of reserpine in the treatment of thyrotoxicosis.

Authors:  J BUCHANAN; W W BUCHANAN; J CROOKS; G E GALE
Journal:  Scott Med J       Date:  1959-10       Impact factor: 0.729

4.  Propranolol and serum calcium in thyrotoxicosis.

Authors:  Y K Seedat; A I Vinik; E G Stewart-Wynne
Journal:  Br Med J       Date:  1970-08-29

5.  Propranolol and iodine-131 in the management of thyrotoxicosis.

Authors:  D R Hadden; D A Montgomery; R G Shanks; J A Weaver
Journal:  Lancet       Date:  1968-10-19       Impact factor: 79.321

6.  The use of propranolol in the surgical treatment of thyrotoxic patients.

Authors:  T C Lee; R J Coffey; J Mackin; M Cobb; J Routon; J J Canary
Journal:  Ann Surg       Date:  1973-06       Impact factor: 12.969

7.  Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias.

Authors:  V Parsons; D Jewitt
Journal:  Postgrad Med J       Date:  1967-12       Impact factor: 2.401

8.  Remission of thyrotoxicosis during treatment with propranolol.

Authors:  D G McLarty; B E Brownlie; W D Alexander; P D Papapetrou; P Horton
Journal:  Br Med J       Date:  1973-05-12

9.  Prediction of hypothyroidism after partial thyroidectomy for thyrotoxicosis.

Authors:  W Michie; C A Pegg; P D Bewsher
Journal:  Br Med J       Date:  1972-01-01
  9 in total
  4 in total

1.  Experience with the use of propranolol in the surgical management of thyrotoxicosis.

Authors:  J R Starling; C G Thomas
Journal:  World J Surg       Date:  1977-03       Impact factor: 3.352

2.  The use of a selective beta-adrenergic receptor blocker for the preoperative preparation of thyrotoxic patients.

Authors:  P Dial; P R Hastings
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

3.  A comparative evaluation of the surgical and radioiodine treatments for Graves' disease.

Authors:  T Harada; M Katagiri; K Shimaoka; K Ito
Journal:  Jpn J Surg       Date:  1989-01

4.  Comparison of propranolol and practolol in the management of hyperthyroidism.

Authors:  L E Murchison; P D Bewsher; M I Chesters; W R Ferrier
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.